SLU-PP-332 (5 mg Vial)
SLU-PP-332 (5 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.
CAT No:
CAS No:
Synonyms/Alias:SLU-PP-332
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
SLU-PP-332 (5 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.
Quickstart
Evidence Base: Preclinical only—in vivo mouse studies with intraperitoneal dosing (25–50 mg/kg twice daily).
Reconstitute: Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration.
Murine dose range: 1250–2500 mcg daily (for a 25 g mouse), administered in two divided doses.
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.
Storage: Lyophilized: −20 °C (−4 °F); reconstituted: 2–8 °C (35.6–46.4 °F).
Notes
Research compound considerations. No human data: SLU-PP-332 has not been tested in human subjects; all evidence is from murine models. Use new sterile syringes for each administration; dispose in a sharps container. Rotate injection sites to reduce local irritation. Document administration times, doses, and any observations. This compound is for research purposes only—not for human consumption.
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (SLU-PP-332, 5 mg each): 8 weeks ≈ 25 vials
12 weeks ≈ 39 vials
16 weeks ≈ 53 vials
Insulin Syringes (U-100): Per week: 14 syringes (2/day)
8 weeks: 112 syringes
12 weeks: 168 syringes
16 weeks: 224 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 8 weeks (25 vials): 75 mL → 8 × 10 mL bottles
12 weeks (39 vials): 117 mL → 12 × 10 mL bottles
16 weeks (53 vials): 159 mL → 16 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each administration. Per week: 28 swabs (4/day)
8 weeks: 224 swabs → recommend 3 × 100-count boxes
12 weeks: 336 swabs → recommend 4 × 100-count boxes
16 weeks: 448 swabs → recommend 5 × 100-count boxes
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China